BOTHELL, Wash.--(BUSINESS WIRE)--
Seattle Genetics, Inc. (SGEN) today highlighted multiple ADCETRIS (brentuximab vedotin) data presentations at the 12th International Conference on Malignant Lymphoma (ICML) being held June 19-22, 2013 in Lugano, Switzerland. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL), that was granted accelerated approval by the FDA in August 2011 for relapsed HL and relapsed sALCL and conditional marketing authorization by the European Commission in October 2012 for relapsed or refractory HL and relapsed or refractory sALCL. Four oral and two poster presentations at ICML illustrated the broad clinical development program for ADCETRIS, including oral presentations describing the ongoing global phase 3 ECHELON-2 trial in frontline mature T-cell lymphoma (MTCL) and data from a phase 2 trial in patients with relapsed MTCL. In addition, an oral presentation included the first report of data from an investigator-sponsored trial evaluating ADCETRIS in first-relapse HL patients as part of a pre-autologous stem cell transplant regimen.
With last years European conditional marketing authorization supporting the use of ADCETRIS as a treatment for patients with relapsed HL and sALCL, this meeting provides us with an opportunity to share important ADCETRIS data with the international physician and patient community as we evaluate ADCETRIS in additional disease settings, said Clay B. Siegall, Ph.D., President and Chief Executive Officer at Seattle Genetics. ADCETRIS is being evaluated for the treatment of CD30-positive malignancies in more than 20 ongoing clinical trials, including three global phase 3 trials. We look forward to the ongoing presentation of important data at medical meetings such as ICML, demonstrating the broad therapeutic potential of ADCETRIS.
Oral Presentations
PET-adapted Sequential Therapy with Brentuximab Vedotin and Augmented-ICE in Relapsed and Refractory Hodgkin Lymphoma (Abstract #141, oral session on Saturday, June 22, 2013 at 8:50 AM CET)
In an ongoing investigator-sponsored phase 2 clinical trial, patients with relapsed or refractory HL have been enrolled to determine whether ADCETRIS can replace the combination chemotherapy regimen ifosfamide, carboplatin and etoposide (ICE) or be used in sequential administration with ICE to increase the rate of pre-transplant FDG-PET normalization (PET-N), which is an important prognostic factor for patients undergoing autologous stem cell transplant (ASCT). At the time of data analysis, 40 patients had been enrolled and 33 patients had completed the treatment program. Key findings presented by Dr. Alison Moskowitz from Memorial Sloan Kettering Cancer Center include:
ADCETRIS is not approved for salvage HL patients who are deemed eligible for ASCT.
Safety and Efficacy of Brentuximab Vedotin for the Treatment of Relapsed Mature T-/NK-Cell Lymphomas (Abstract #152, oral session on Saturday, June 22, 2013 at 10:00 AM CET)
In an encore presentation from the 2012 American Society of Hematology (ASH) Annual Meeting, data were highlighted from a subset of patients in an ongoing phase 2 clinical trial evaluating ADCETRIS in CD30-positive non-Hodgkin lymphoma. The trial is designed to assess the antitumor activity, duration of response and safety profile of ADCETRIS in these patients. At the time of data analysis, 29 patients with MTCL had been enrolled, including 11 with angioimmunoblastic T-cell lymphoma (AITL) and 18 with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). The median number of prior systemic therapies in both lymphoma classifications was two. Key findings include:
ADCETRIS is not approved for the treatment of the MTCL subtypes described in this presentation.
See the article here:
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Clinical Data at International Conference on Malignant ...
- Seattle Genetics Reports Fourth Quarter and Year 2011 Financial Results [Last Updated On: February 13th, 2012] [Originally Added On: February 13th, 2012]
- Seattle Genetics Loss Narrows; But Stock Down - Update [Last Updated On: February 14th, 2012] [Originally Added On: February 14th, 2012]
- Seattle Genetics Highlights Updated Survival Data from ADCETRIS® Pivotal Trial in Patients with Relapsed or Refractory ... [Last Updated On: June 15th, 2012] [Originally Added On: June 15th, 2012]
- A Growth-Free Quarter -- and That's OK [Last Updated On: August 11th, 2012] [Originally Added On: August 11th, 2012]
- Seattle Genetics and Millennium Complete Enrollment in Phase III AETHERA Trial of ADCETRIS® for Post-Transplant ... [Last Updated On: September 25th, 2012] [Originally Added On: September 25th, 2012]
- ORF Genetics to Offer endotoxin- and Animal-free FGFb and mLIF for Stem Cell Research [Last Updated On: October 4th, 2012] [Originally Added On: October 4th, 2012]
- FAQ-4 of 19: What Chance That Stem Cells Will Help Me When I Get Stem Cell Therapy - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- FAQ-4 of 19: What Is My Chance of Success With Stem Cells in Stem Cell Therapy - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- FAQ-3 of 19 -How Do Stem Cells Work in Stem Cell Therapy? - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- Stem Cell Therapy for osteoarthritis Cosmetic Surgery Thailand Review - Urban Beauty Thailand - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- [RMS] C-Class Stem Cell Processing Center (SPC) - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- FAQ-4 19- What Chances for Stem Cell Success When I Get Stem Cell Therapy? - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- FAQ-4 19- What Chance Stem Cells Can Help Me After Stem Cell Therapy? - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- Is stem cell therapy really effective? - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- STEM CELL THERAPY cure HIV patient - Video [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- Seattle Genetics Announces ADCETRIS® Receives European Commission Conditional Marketing Authorization [Last Updated On: November 6th, 2012] [Originally Added On: November 6th, 2012]
- Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in Relapsed Hodgkin Lymphoma and Other CD30-Positive ... [Last Updated On: December 13th, 2012] [Originally Added On: December 13th, 2012]
- Seattle Genetics Highlights Data Presentations from Genentech ADC Collaborator Programs at ASH Annual Meeting [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Seattle Genetics Highlights Next Generation Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Clinical Data from NewLink Genetics' HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Seattle Genetics Announces Data from Investigator-Sponsored Trials of ADCETRIS® (Brentuximab Vedotin) in Cutaneous T ... [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Seattle Genetics Reports Data from Phase I Trial of ADCETRIS® (Brentuximab Vedotin) in Front-line Hodgkin Lymphoma at ... [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Seattle Genetics to test possible new Adcetris use [Last Updated On: December 16th, 2012] [Originally Added On: December 16th, 2012]
- Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference [Last Updated On: December 18th, 2012] [Originally Added On: December 18th, 2012]
- Data From SGEN on Cancer Candidate [Last Updated On: January 30th, 2013] [Originally Added On: January 30th, 2013]
- Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Treatment of Relapsed or Refractory Hodgkin Lymphoma ... [Last Updated On: February 2nd, 2013] [Originally Added On: February 2nd, 2013]
- Canada Approves Seattle Genetics' Adcetris [Last Updated On: February 5th, 2013] [Originally Added On: February 5th, 2013]
- Canada Approves Seattle Genetics' Adcetris - Analyst Blog [Last Updated On: February 5th, 2013] [Originally Added On: February 5th, 2013]
- ADC Data from Seattle Genetics [Last Updated On: April 11th, 2013] [Originally Added On: April 11th, 2013]
- Genetics of alcoholism research [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Genetics Policy Institute and univerCELLmarket to co-publish 360 – the Free Newsletter Covering Stem Cells and ... [Last Updated On: April 29th, 2013] [Originally Added On: April 29th, 2013]
- Genetics Policy Institute and univerCELLmarket to co-publish 360 – the Free Newsletter Covering Stem Cells and ... [Last Updated On: May 2nd, 2013] [Originally Added On: May 2nd, 2013]
- Genetics Policy Institute Opens Washington, D.C. Office [Last Updated On: May 7th, 2013] [Originally Added On: May 7th, 2013]
- Seattle Genetics Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with ... [Last Updated On: June 11th, 2013] [Originally Added On: June 11th, 2013]
- Seattle Genetics Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with ... [Last Updated On: June 17th, 2013] [Originally Added On: June 17th, 2013]
- Takeda and Seattle Genetics Highlight Post-Hoc Analysis Examining Progression-free Survival with ADCETRIS® ... [Last Updated On: June 19th, 2013] [Originally Added On: June 19th, 2013]
- SGEN/Astellas to Co-Develop Another ADC [Last Updated On: June 30th, 2013] [Originally Added On: June 30th, 2013]
- Life Stem Genetics is Pleased to Announce That It Has Completed the First $500,000 Private Placement of the Recently ... [Last Updated On: October 22nd, 2013] [Originally Added On: October 22nd, 2013]
- Life Stem Genetics Strengthens Its Executive Advisory Board by Adding MBAs Matthew Sullivan and Shahab Bakhtyar [Last Updated On: October 29th, 2013] [Originally Added On: October 29th, 2013]
- Seattle Genetics, Inc. Posts Record Adcetris Sales [Last Updated On: October 31st, 2014] [Originally Added On: October 31st, 2014]
- Inbreeding - Wikipedia, the free encyclopedia [Last Updated On: May 9th, 2015] [Originally Added On: May 9th, 2015]
- Genetics of Colorectal Cancer - National Cancer Institute [Last Updated On: July 16th, 2015] [Originally Added On: July 16th, 2015]
- Seattle Genetics: Advancing Antibody-Drug Conjugates for ... [Last Updated On: August 18th, 2015] [Originally Added On: August 18th, 2015]
- genetics | Britannica.com [Last Updated On: August 25th, 2015] [Originally Added On: August 25th, 2015]
- Genetics and Genetic Disorders and Diseases - WebMD [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Genetics - Biology [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Genetics: MedlinePlus Medical Encyclopedia [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Genetics of Skin Cancer - National Cancer Institute [Last Updated On: September 13th, 2015] [Originally Added On: September 13th, 2015]
- Genetics in Georgia | New Georgia Encyclopedia [Last Updated On: September 15th, 2015] [Originally Added On: September 15th, 2015]
- Faculty & Staff | Directory | Medical Partnership [Last Updated On: October 5th, 2015] [Originally Added On: October 5th, 2015]
- Genetics | Learn Science at Scitable [Last Updated On: October 12th, 2015] [Originally Added On: October 12th, 2015]
- Genetics - Wikipedia, the free encyclopedia [Last Updated On: October 15th, 2015] [Originally Added On: October 15th, 2015]
- Department of Genetics || University of Pennsylvania [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Genetics News - Genetics Science, Genetics Technology, Genetics [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Home > Genetics | Yale School of Medicine [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Ology Genetics - AMNH [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- About Genetics | Understanding Genetics [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Genetics | Article about genetics by The Free Dictionary [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Genetics - Simple English Wikipedia, the free encyclopedia [Last Updated On: October 21st, 2015] [Originally Added On: October 21st, 2015]
- Cell Size and Scale - Learn Genetics [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Genetics of Prostate Cancer (PDQ)Health Professional ... [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Genetics of Skin Cancer (PDQ)Health Professional Version ... [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Basic Genetics [Last Updated On: September 26th, 2016] [Originally Added On: September 26th, 2016]
- genetics facts, information, pictures | Encyclopedia.com ... [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- Genetics - Wikipedia [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- How culture, passion and genetics are fueling a Nigerian takeover of US sports - CBS sports.com (blog) [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- After vote, Accelerated Genetics slated to merge - La Crosse Tribune [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Autism genetics, explained | Spectrum | Autism Research News - Spectrum [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- The problematics of genetics and the Aryan issue - The Hindu [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- North American genetics take centre stage in Wicklow - Agriland [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Genetics may lie at the heart of crop yield limitation - Phys.org - Phys.Org [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Research in genetics promises a long-term cure to diseases : Tony Mira, CEO at Ajuba International LLC - ETHealthworld.com [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- NewLink Genetics to Host Its Second Quarter 2017 Financial Results Conference Call on July 28, 2017 - GlobeNewswire (press release) [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Immunotherapy drug targets tumor's genetics instead of body part - Monroe Evening News [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Getting tumors tested for genetics is the latest theory to help drugs target cancer - The Denver Post [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Konica Minolta, With Eye on Health Care, Nears Deal for US Genetics Firm - New York Times [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Memphis Researchers Planning Big Upgrades to Online Genetics Database - Memphis Daily News [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Mosaic (genetics) - Simple English Wikipedia, the free ... [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Is There a Genetic Limit to Milk Production? - Dairy Herd Management [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Why Myriad Genetics Stock Rocketed 26.3% Higher in June -- The ... - Motley Fool [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]